Suntrust Banks’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Suntrust Banks’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$897K	Buy	11,763 +719	+7%	+$59.8K	﹤0.01%	771
2019 Q2	$969K	Buy	11,044 +10	+0.1%	+$853	0.01%	789
2019 Q1	$999K	Sell	11,034 -351	-3%	-$29.9K	0.01%	763
2018 Q4	$816K	Sell	11,385 -1,459	-11%	-$118K	﹤0.01%	759
2018 Q3	$1.23M	Sell	12,844 -1,485	-10%	-$144K	0.01%	693
2018 Q2	$1.36M	Buy	14,329 +2,818	+24%	+$259K	0.01%	673
2018 Q1	$1.01M	Sell	11,511 -3,544	-24%	-$324K	0.01%	720
2017 Q4	$1.28M	Buy	15,055 +1,458	+11%	+$122K	0.01%	643
2017 Q3	$1.18M	Sell	13,597 -586	-4%	-$47K	0.01%	691
2017 Q2	$1.09M	Sell	14,183 -759	-5%	-$53.8K	0.01%	634
2017 Q1	$1.04M	Sell	14,942 -2,589	-15%	-$174K	0.01%	648
2016 Q4	$1.04M	Buy	17,531 +532	+3%	+$32.8K	0.01%	762
2016 Q3	$1.13M	Buy	16,999 +9,123	+116%	+$564K	0.01%	722
2016 Q2	$425K	Buy	7,876 +248	+3%	+$13.6K	﹤0.01%	1009
2016 Q1	$393K	Sell	7,628 -2,450	-24%	-$127K	﹤0.01%	1013
2015 Q4	$706K	Buy	+10,078	New	+$687K	﹤0.01%	824
2015 Q3	–	Sell	-11,334	Closed	-$952K	–	1325
2015 Q2	$952K	Sell	11,334 -876	-7%	-$68.1K	0.01%	655
2015 Q1	$917K	Sell	12,210 -444	-4%	-$31K	0.01%	635
2014 Q4	$785K	Buy	12,654 +441	+4%	+$25.1K	0.01%	669
2014 Q3	$634K	Buy	12,213 +7,500	+159%	+$382K	﹤0.01%	864
2014 Q2	$241K	Sell	4,713 -4,050	-46%	-$183K	﹤0.01%	1296
2014 Q1	$415K	Buy	8,763 +3,669	+72%	+$188K	﹤0.01%	1424
2013 Q4	$221K	Buy	+5,094	New	+$211K	﹤0.01%	1654

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Suntrust Banks's XBI Position: Q3 2019 in Review

Suntrust Banks increased its State Street SPDR S&P Biotech ETF (XBI) stake by 6.5% in Q3 2019, buying an estimated $59.8K and bringing the position to 11,763 shares worth $897K. The position accounts for ﹤0.01% of the portfolio, ranked #771.

Suntrust Banks first reported a position in XBI in Q4 2013 and has held it in 23 quarters since. The position peaked at $1.36M in Q2 2018. 406 funds tracked by Wall St. Rank hold XBI as of Q3 2019.

Suntrust Banks held 11,763 shares of State Street SPDR S&P Biotech ETF worth $897K as of Q3 2019.
Suntrust Banks bought 719 State Street SPDR S&P Biotech ETF shares in Q3 2019, an estimated $59.8K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #771 holding.
Suntrust Banks first reported a position in State Street SPDR S&P Biotech ETF in Q4 2013 and has held it in 23 quarters since.
Suntrust Banks's State Street SPDR S&P Biotech ETF position peaked at $1.36M in Q2 2018.
406 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.